The lancet oncology CZ.
2014 ;
13 (4) :
285-296.
- MeSH
- Adult MeSH
- Fluorouracil therapeutic use MeSH
- Antibodies, Monoclonal, Humanized therapeutic use MeSH
- Infusions, Intravenous MeSH
- Neoplasm Invasiveness pathology MeSH
- Camptothecin analogs & derivatives therapeutic use MeSH
- Colorectal Neoplasms drug therapy mortality pathology MeSH
- Leucovorin therapeutic use MeSH
- Middle Aged MeSH
- Humans MeSH
- Maximum Tolerated Dose MeSH
- Survival Rate MeSH
- Adolescent MeSH
- Young Adult MeSH
- Disease-Free Survival MeSH
- Prognosis MeSH
- Antineoplastic Combined Chemotherapy Protocols therapeutic use MeSH
- Drug Administration Schedule MeSH
- Aged MeSH
- Neoplasm Staging MeSH
- Patient Selection MeSH
- Treatment Outcome MeSH
- Dose-Response Relationship, Drug MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Clinical Trial, Phase III MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Randomized Controlled Trial MeSH
- Comparative Study MeSH
- Geographicals
- Germany MeSH
- Austria MeSH
Onkologie (Olomouc, Print).
2013 ;
7 (2) :
102.
- MeSH
- Medical Oncology * MeSH
- Publication type
- Interview MeSH
Journal of Clinical Oncology (České vyd.).
2012 ;
4 (Speciální číslo) :
110.
ASCO Annual Meeting.
2012 ;
4 (Speciální číslo) :
110.
- Publication type
- Meeting Abstract MeSH
